SCHEMBL8309988

SCHEMBL8309988

ON=Cc1ccc(-c2ccccc2)c(CCOC2CCCCO2)c1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.43
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
MGLL Q99685 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309114 0.83 KDM4C (0.50) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL6933743 0.81 KDM4C (0.43) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8305338 0.79 KDM4C (0.41) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8304469 0.78 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8307664 0.78 KDM4C (0.47) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8305782 0.74 KDM4C (0.55) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8309642 0.70 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL10679113 0.70 KDM4C (0.53) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL8306736 0.69 KDM4C (0.48) KDM4CMEN1KMT2AL3MBTL1RAB9A
SCHEMBL6879618 0.69 KDM4C (0.58) KDM4CMEN1KMT2AL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed